Ravi Vumma

Ravi Vumma

Auto-generated profile, based on publicly available information

Ravi Vumma

School of Health and Medical Sciences, Örebro University, Örebro, Sweden

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2011 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
JJJessica Johansson
Jessica Johansson
MLMagnus Landgren
Magnus Landgren
EFElisabeth Fernell
Elisabeth Fernell
RVRavi Vumma
Ravi Vumma
AÅArne Åhlin
Arne Åhlin
NVNikolaos Venizelos
Nikolaos Venizelos
Background: The catecholaminergic and serotonergic neurotransmitter systems are implicated in the pathophysiology of attention-deficit/hyperactivity disorder (ADHD). The amino acid tyrosine is the precursor for synthesis of the catecholamines dopamine and norepinephrine, while tryptophan is the precursor of serotonin. A disturbed transport of tyrosine, as well as other amino acids, has been found in a number of other psychiatric disorders, such as schizophrenia, bipolar disorder and autism, when using the fibroblast cell model. Hence, the aim of this study was to explore whether children with ADHD may have disturbed amino acid transport. Methods: Fibroblast cells were cultured from skin biopsies obtained from 14 boys diagnosed with ADHD and from 13 matching boys without a diagnosis of a developmental disorder. Transport of the amino acids tyrosine, tryptophan and alanine across the cell membrane was measured by the cluster tray method. The kinetic parameters, maximal transport capacity (V max ) and affinity constant (K m ) were determined. Any difference between the two groups was analyzed by Student's unpaired t-test or the Mann Whitney U test. Results: The ADHD group had significantly decreased V max (p = 0.039) and K m (increased affinity) (p = 0.010) of tryptophan transport in comparison to controls. They also had a significantly higher V max of alanine transport (p = 0.031), but the Km of alanine transport did not differ significantly. There were no significant differences in any of the kinetic parameters regarding tyrosine transport in fibroblasts for the ADHD group. Conclusions: Tryptophan uses the same transport systems in both fibroblasts and at the blood brain barrier (BBB). Hence, a decreased transport capacity of tryptophan implies that less tryptophan is being transported across the BBB in the ADHD group. This could lead to deficient serotonin access in the brain that might cause disturbances in both the serotonergic and the catecholaminergic neurotransmitter systems, since these systems are highly interconnected. The physiological importance of an elevated transport capacity of alanine to the brain is not known to date.

23 November 2012 in American Journal of Nephrology
Verified
Journal Article
Open access
PDF file
IDIsak Demirel
Isak Demirel
RVRavi Vumma
Ravi Vumma
CMCamilla Mohlin
Camilla Mohlin
LSLovisa Svensson
Lovisa Svensson
SSSusanne Säve
Susanne Säve
KPKatarina Persson
Katarina Persson
Background/Aims: Increased nitric oxide (NO) production or inducible form of NO synthase activity have been documented in patients suffering from urinary tract infection (UTI), but the role of NO in this infection is unclear. We investigated whether NO can affect the host response in human renal epithelial cells by modulating IL-6 production and mRNA expression. Methods: The human renal epithelial cell line A498 was infected with a uropathogenic Escherichia coli (UPEC) strain and/or the NO donor DETA/NO. The IL-6 production and mRNA expression were evaluated by ELISA and real-time RT-PCR. IL-6 mRNA stability was evaluated by analyzing mRNA degradation by real-time RT-PCR. Results: DETA/NO caused a significant (p < 0.05) increase in IL-6 production. Inhibitors of p38 MAPK and ERK1/2 signaling, but not JNK, were shown to significantly suppress DETA/NO-induced IL-6 production. UPEC-induced IL-6 production was further increased (by 73 ± 23%, p < 0.05) in the presence of DETA/NO. The IL-6 mRNA expression increased 2.1 ± 0.17-fold in response to DETA/NO, while the UPEC-evoked increase was pronounced (20 ± 4.5-fold). A synergistic effect of DETA/NO on UPEC-induced IL-6 expression was found (33 ± 7.2-fold increase). The IL-6 mRNA stability studies showed that DETA/NO partially attenuated UPEC-induced degradation of IL-6 mRNA. Conclusions: NO was found to stimulate IL-6 in renal epithelial cells through p38 MAPK and ERK1/2 signaling pathways and also to increase IL-6 mRNA stability in UPEC-infected cells. This study proposes a new role for NO in the host response during UTI by modulating the transcription and production of the cytokine IL-6.

1 August 2011 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
SSSusanne Säve
Susanne Säve
CMCamilla Mohlin
Camilla Mohlin
RVRavi Vumma
Ravi Vumma
KPKatarina Persson
Katarina Persson
Adenosine has been identified as a significant inhibitor of inflammation by acting on adenosine A2Areceptors. In this study, we examined the role of adenosine and A2Areceptors in the transmigration of human neutrophils across anin vitromodel of the transitional bladder urothelium. Human uroepithelial cells (UROtsa) were grown on transwell inserts; uropathogenicEscherichia coli(UPEC) and neutrophils were added to the transwell system; and the number of migrating neutrophils was evaluated. Reverse transcription-PCR (RT-PCR), immunohistochemistry, and flow cytometry were used to investigate the expression of adenosine receptors, the epithelial adhesion molecule ICAM-1, and the neutrophil integrin CD11b. Levels of proinflammatory interleukin-8 (IL-8) and phosphorylated IκBα were measured by enzyme-linked immunosorbent assays (ELISA) and Luminex assays, respectively. The neutrophils expressed all four adenosine receptor subtypes (A1, A2A, A2B, and A3receptors), but A3receptors were not expressed by UROtsa cells. UPEC stimulated neutrophil transuroepithelial migration, which was significantly decreased in response to the specific A2Areceptor agonist CGS 21680. The inhibitory effect of CGS 21680 on neutrophil migration was reversed by the A2Areceptor antagonist SCH 58261. The production of chemotactic IL-8 and the expression of the adhesion molecule ICAM-1 or CD11b were not significantly affected by CGS 21680. However, a significant decrease in the level of phosporylated IκBα was revealed in response to CGS 21680. In conclusion, UPEC infectionin vitroevoked neutrophil migration through a multilayered human uroepithelium. The UPEC-evoked neutrophil transmigration decreased in response to A2Areceptor activation, possibly through inhibition of NF-κB signaling pathways.

1 March 2008 in Neuroscience Letters
Verified
Journal Article
Closed access
RVRavi Vumma
Ravi Vumma
FWFrits-Axel Wiesel
Frits-Axel Wiesel
LFLena Flyckt
Lena Flyckt
LBLars Bjerkenstedt
Lars Bjerkenstedt
NVNikolaos Venizelos
Nikolaos Venizelos

19 June 2009 in Neuroscience Letters
Verified
Journal Article
Closed access
MPM.L. Persson
M.L. Persson
JJJ. Johansson
J. Johansson
RVR. Vumma
R. Vumma
JRJ. Raita
J. Raita
LBL. Bjerkenstedt
L. Bjerkenstedt
NVN. Venizelos
N. Venizelos

1 January 2011 in International Journal of Tryptophan Research
Verified
Journal Article
Open access
RVRavi Vumma
Ravi Vumma
JJJessica Johansson
Jessica Johansson
TLTommy Lewander
Tommy Lewander
NVNikolaos Venizelos
Nikolaos Venizelos
There are indications that serotonergic neurotransmission is disturbed in several psychiatric disorders. One explanation may be disturbed transport of tryptophan (precursor for serotonin synthesis) across cell membranes. Human fibroblast cells offer an advantageous model to study the transport of amino acids across cell membranes, since they are easy to propagate and the environmental factors can be controlled. The aim of this study was to functionally characterize tryptophan transport and to identify the main transporters of tryptophan in fibroblast cell lines from healthy controls. Tryptophan kinetic parameters ( Vmax and Km) at low and high concentrations were measured in fibroblasts using the cluster tray method. Uptake of 3H (5)-L-tryptophan at different concentrations in the presence and absence of excess concentrations of inhibitors or combinations of inhibitors of amino acid transporters were also measured. Tryptophan transport at high concentration (0.5 mM) had low affinity and high Vmax and the LAT1 isoform of system-L was responsible for approximately 40% of the total uptake of tryptophan. In comparison, tryptophan transport at low concentration (50 nM) had higher affinity, lower Vmax and approximately 80% of tryptophan uptake was transported by system-L with LAT1 as the major isoform. The uptake of tryptophan at the low concentration was mainly sodium (Na+) dependent, while uptake at high substrate concentration was mainly Na+ independent. A series of different transporter inhibitors had varying inhibitory effects on tryptophan uptake. This study indicates that tryptophan is transported by multiple transporters that are active at different substrate concentrations in human fibroblast cells. The tryptophan transport trough system-L was mainly facilitated by the LAT1 isoform, at both low and high substrate concentrations of tryptophan.